anti cd80 (Bio X Cell)
Bio X Cell is a verified supplier 
Bio X Cell manufactures this product 
93
Structured Review
Bio X Cell
anti cd80
Anti Cd80, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd80/InVivoMAb+anti-mouse+CD80/pmc11228532-119-4-7
Average 93 stars, based on 14 article reviews
Anti Cd80, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd80/InVivoMAb+anti-mouse+CD80/pmc11228532-119-4-7
Average 93 stars, based on 14 article reviews
anti cd80 - by Bioz Stars,
2026-11
93/100 stars
Images
Related Articles
Blocking Assay:Article Title: PD-1 or CTLA-4 blockade promotes CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in mice Article Snippet: For Treg depletion experiments, mice were injected i.p. with 250 μg depleting mouse IgG2a isotype CD25 mAbs ( ) (modified clone of PC61, Evitria) in 100 μL PBS on day –1 prior to RT and on day 5. .. Blocking mAbs against CTLA-4 (UC10-4F10-11, Bio X Cell), PD-1 (RMP1-14, Bio X Cell), Article Title: PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration Article Snippet: .. Blocking antibodies against mouse PD-1 (Rmp1-14, BE0146, use at final 5 to 20 ug/ml), mouse PD-L1 (10F.9G2, BE0101, use at final 5-20ug/ml), Article Title: Monocyte-derived cells promote transient insult-induced brain injury by enhancing CD8 + T cell response. Article Snippet: .. In vivo drug/antibody treatments Anti-CD80/86 To block B7-1 and B7-2, 200 μg Injection:Article Title: PD-1 or CTLA-4 blockade promotes CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in mice Article Snippet: For Treg depletion experiments, mice were injected i.p. with 250 μg depleting mouse IgG2a isotype CD25 mAbs ( ) (modified clone of PC61, Evitria) in 100 μL PBS on day –1 prior to RT and on day 5. .. Blocking mAbs against CTLA-4 (UC10-4F10-11, Bio X Cell), PD-1 (RMP1-14, Bio X Cell), Article Title: Monocyte-derived cells promote transient insult-induced brain injury by enhancing CD8 + T cell response. Article Snippet: .. In vivo drug/antibody treatments Anti-CD80/86 To block B7-1 and B7-2, 200 μg In Vivo:Article Title: A transgenic mouse model for HLA-B*57:01–linked abacavir drug tolerance and reactivity Article Snippet: To block PD-1 in vivo, 0.2 mg anti–PD-1 mAb was administered by i.p. injection (clone RPM1-14, BioXcell). .. In vivo neutralization of CD86 and/or CD80 was achieved by treating animals with CTLA-4–Ig (ORENCIA [abatacept], Bristol-Myers Squibb) or Article Title: Monocyte-derived cells promote transient insult-induced brain injury by enhancing CD8 + T cell response. Article Snippet: .. In vivo drug/antibody treatments Anti-CD80/86 To block B7-1 and B7-2, 200 μg Neutralization:Article Title: A transgenic mouse model for HLA-B*57:01–linked abacavir drug tolerance and reactivity Article Snippet: To block PD-1 in vivo, 0.2 mg anti–PD-1 mAb was administered by i.p. injection (clone RPM1-14, BioXcell). .. In vivo neutralization of CD86 and/or CD80 was achieved by treating animals with CTLA-4–Ig (ORENCIA [abatacept], Bristol-Myers Squibb) or Purification:Article Title: PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration Article Snippet: .. Blocking antibodies against mouse PD-1 (Rmp1-14, BE0146, use at final 5 to 20 ug/ml), mouse PD-L1 (10F.9G2, BE0101, use at final 5-20ug/ml), Article Title: PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration Article Snippet: .. Functional grade purified antibodies against mouse PD-1 (Rmp1-14), mouse PD-L1 (10 F.9G2), Mouse Assay:Article Title: Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade Article Snippet: In parallel, cells were harvested, washed and pre-incubated with anti-CD16/32 Ab (clone 93, eBioscience) for 20 min at 4 °C and then stained to discriminate populations and markers of interest using the antibodies listed in Supplementary information, Table S . In vivo treatments . .. Mice were treated intraperitoneally (i.p.) when tumors became palpable (20 to 25 mm2) with anti-PD-1 mAb (250 μg/mouse; clone RMP1–14, BioXcell, NH, USA), with or without Control:Article Title: Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade Article Snippet: In parallel, cells were harvested, washed and pre-incubated with anti-CD16/32 Ab (clone 93, eBioscience) for 20 min at 4 °C and then stained to discriminate populations and markers of interest using the antibodies listed in Supplementary information, Table S . In vivo treatments . .. Mice were treated intraperitoneally (i.p.) when tumors became palpable (20 to 25 mm2) with anti-PD-1 mAb (250 μg/mouse; clone RMP1–14, BioXcell, NH, USA), with or without Functional Assay:Article Title: PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration Article Snippet: .. Functional grade purified antibodies against mouse PD-1 (Rmp1-14), mouse PD-L1 (10 F.9G2), Irradiation:Article Title: Monocyte-derived cells promote transient insult-induced brain injury by enhancing CD8 + T cell response. Article Snippet: .. In vivo drug/antibody treatments Anti-CD80/86 To block B7-1 and B7-2, 200 μg |
